Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing
Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule
Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328